225 related articles for article (PubMed ID: 17145324)
1. Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review.
Da Fonseca CO; Masini M; Futuro D; Caetano R; Gattass CR; Quirico-Santos T
Surg Neurol; 2006 Dec; 66(6):611-5. PubMed ID: 17145324
[TBL] [Abstract][Full Text] [Related]
2. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation.
DA Fonseca CO; Teixeira RM; Silva JC; DE Saldanha DA Gama Fischer J; Meirelles OC; Landeiro JA; Quirico-Santos T
Anticancer Res; 2013 Dec; 33(12):5625-31. PubMed ID: 24324108
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
da Fonseca CO; Schwartsmann G; Fischer J; Nagel J; Futuro D; Quirico-Santos T; Gattass CR
Surg Neurol; 2008 Sep; 70(3):259-66; discussion 266-7. PubMed ID: 18295834
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity analysis in an anaplastic oligodendroglioma arising after radiation therapy.
Hata N; Shono T; Mizoguchi M; Matsumoto K; Guan Y; Nagata S; Hayashi K; Iwaki T; Sasaki T
Neurol Res; 2007 Oct; 29(7):723-6. PubMed ID: 17553214
[TBL] [Abstract][Full Text] [Related]
6. Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Da Fonseca CO; Silva JT; Lins IR; Simão M; Arnobio A; Futuro D; Quirico-Santos T
Invest New Drugs; 2009 Dec; 27(6):557-64. PubMed ID: 19139816
[TBL] [Abstract][Full Text] [Related]
7. Case 38-2016. A 52-Year-Old Woman with Recurrent Oligodendroglioma.
Chi AS; Cahill DP; Larvie M; Louis DN
N Engl J Med; 2016 Dec; 375(24):2381-2389. PubMed ID: 27974037
[No Abstract] [Full Text] [Related]
8. B cell non-Hodgkin cerebral lymphoma associated with an anaplastic oligodendroglioma.
Fewings PE; Bhattacharyya D; Crooks D; Morris K
Clin Neuropathol; 2002; 21(6):243-7. PubMed ID: 12489671
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma.
da Fonseca CO; Simão M; Lins IR; Caetano RO; Futuro D; Quirico-Santos T
J Cancer Res Clin Oncol; 2011 Feb; 137(2):287-93. PubMed ID: 20401670
[TBL] [Abstract][Full Text] [Related]
10. Treatment of oligodendroglioma: an update.
Paleologos NA; Cairncross JG
Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
[TBL] [Abstract][Full Text] [Related]
11. Glioblastomatous recurrence of oligodendroglioma remote from the original site: a case report.
Kocaeli H; Yakut T; Bekar A; Taşkapilioğlu O; Tolunay S
Surg Neurol; 2006 Dec; 66(6):627-30; discussion 630-1. PubMed ID: 17145331
[TBL] [Abstract][Full Text] [Related]
12. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls of conservative treatments of multiple probable cerebral cavernous malformations (CCMs): clinicopathological features of CCMs coexisting with vasculogenic mimicry in an anaplastic oligodendroglioma.
Yamamoto J; Shimajiri S; Miyaoka R; Nishizawa S
Brain Tumor Pathol; 2014 Jul; 31(3):215-21. PubMed ID: 24337536
[TBL] [Abstract][Full Text] [Related]
14. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
[TBL] [Abstract][Full Text] [Related]
15. Collision tumor of anaplastic oligodendroglioma and gangliocytoma: a case report.
Takeuchi Y; Kanamori M; Kumabe T; Saito R; Sonoda Y; Watanabe M; Tominaga T
Brain Tumor Pathol; 2009; 26(2):89-93. PubMed ID: 19856221
[TBL] [Abstract][Full Text] [Related]
16. Scalp Metastasis of Anaplastic Oligodendroglioma.
Wu L; Ou Y; Liu B; Liu W
World Neurosurg; 2019 Aug; 128():448-451. PubMed ID: 31125773
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.
van den Bent MJ; Taphoorn MJ; Brandes AA; Menten J; Stupp R; Frenay M; Chinot O; Kros JM; van der Rijt CC; Vecht ChJ; Allgeier A; Gorlia T;
J Clin Oncol; 2003 Jul; 21(13):2525-8. PubMed ID: 12829671
[TBL] [Abstract][Full Text] [Related]
18. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
Webre C; Shonka N; Smith L; Liu D; De Groot J
Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
20. Current diagnosis and treatment of oligodendroglioma.
Engelhard HH
Neurosurg Focus; 2002 Feb; 12(2):E2. PubMed ID: 16212319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
